Ann Conkle
Mar 20, 2012

An aspirin a day for cancer?

Aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be an extremely potent cancer-fighter. The researchers created a hybrid of two earlier formulations, which they have called ‘NOSH-aspirin.’ The new designer aspirin curbed the growth of 11 different types of human cancer cells in culture without harming normal cells, reported a paper published this month in Medicinal Chemistry Letters. The cancers controlled included colon, pancreatic, lung, prostate, breast, and leukemia. The aspirin compound also shrank human colon cancer tumors by 85 percent in live animals, again without adverse effects, according to a second paper in press by the City College researchers and colleague Kenneth Olson of Indiana University School of Medicine, South Bend. 

Companies
1
Patents
1
0 Comments
Related Articles
Ann Conkle
Jan 18, 2012
Aspirin could prevent cervical cancer in HIV-infected women
Research suggests that aspirin could inhibit the development of cervical cancer in HIV-infected women. Authors of a new report discovered... Read More
Kristin Wall
Feb 22, 2012
Aspirin resistance: New patented method identifies people who don't respond to aspirin
If you’re like the majority of Americans, you take an aspirin when you have a headache, or possibly as a... Read More
Elisabeth Manville
Feb 29, 2012
New ‘NOSH aspirin’ inhibits growth of cancer cells in lab tests
Scientists have developed a new ‘NOSH aspirin’ that combines two new forms of aspirin to create a hybrid that could... Read More